Target intelligence / Profile preview

Disulfide bond in protein and peptide

Molecular classification
Other
01

Overview

Disulfide bonds are covalent linkages formed between the sulfur atoms of two cysteine residues in proteins or peptides (R-S-S-R'). They are crucial in stabilizing the three-dimensional structure of many proteins and peptides, especially those that function extracellularly or are secreted. These bonds play essential roles in protein folding, structural stability, and the regulation of biological activity. Their correct formation and maintenance are vital for protein function; mispairing or reduction can cause protein misfolding, aggregation, and disease. Disulfide bonds also act as redox-sensitive switches, modulating activity in response to the cellular or extracellular environment. They are not a protein, receptor, or classical therapeutic target but rather a chemical feature or motif within proteins and peptides, whose modulation can be leveraged in biotechnology and therapy (e.g., through reducing agents)[1][2][4][5]. Disulfide bond in protein and peptide is not a classical drug target (such as a receptor or enzyme) but a structural motif or chemical property. If a structured database is needed, this would be marked as an incorrect entry for "target" because it is not a unique protein, receptor, or enzyme; rather, it is a ubiquitous structural feature found in many proteins. The field "is_incorrect" should be set to true. The biologically relevant proteins involved in the formation or reduction of disulfide bonds include enzyme families such as protein disulfide isomerase (PDI) and thioredoxins, which are established therapeutic targets in some contexts[2][4].

Other names
Disulfide bridgeS-S bondcystine linkageprotein disulfide bond
02

Mechanism of action

Reduction of disulfide bonds (protein denaturation, chemical reduction). Modulation of redox state (affecting protein function or folding). Inhibition or facilitation of disulfide bond formation (in protein engineering or therapeutics).

03

Biological functions

Protein foldingProtein stabilityStructural integrityRegulation of biological activity
04

Disease associations

Neurodegenerative diseaseProtein misfolding disordersAggregation diseases (e.g., Alzheimer's)Other
05

Safety considerations

Risk of unwanted immunogenicity if mispaired or reduced in therapeutic proteinsStability concerns in biologics if disulfide bonds are not properly formedProtein aggregation and cellular stress upon improper disulfide bond formation or reduction
06

Interacting drugs

Dithiothreitol (DTT)

3 more in the full profile.

Beyond the preview

Go deeper on Disulfide bond in protein and peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide bond in protein and peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call